Search

Monika Kvassheim

Therapeutic evaluation of [212Pb]Pb-AB001 and [177Lu]Lu-PSMA-617 in a mouse model of disseminated prostate cancer
First-in-Human Phase 0 Study of AB001, a Prostate-Specific Membrane Antigen-Targeted 212Pb Radioligand, in Patients with Metastatic Castration-Resistant Prostate Cancer
Twisted clustered pinhole collimation for improved high-energy preclinical SPECT/PET
Imaging of 212Pb in mice with a clinical SPECT/CT
Optimized SPECT Imaging of 224Ra α-Particle Therapy by 212Pb Photon Emissions
Correction to: Quantitative SPECT/CT imaging of lead-212: a phantom study
Radionuclides for Targeted Therapy: Physical Properties
Quantitative SPECT/CT imaging of lead-212: a phantom study

Published with Hugo Blox Builder — the free, open source website builder that empowers creators.